NASOPHARYNGEAL CARCINOMA
Clinical trials for NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in keeping throat cancer at bay
Disease control CompletedThis study tested whether adding pembrolizumab (an immunotherapy drug) after standard chemoradiation could help prevent cancer from returning in patients with locally advanced nasopharyngeal carcinoma (a type of throat cancer). The trial involved 53 patients who received up to on…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo trial aims to boost fight against aggressive nasal cancer
Disease control CompletedThis study tested whether a new three-drug chemotherapy combination (APF) given before standard radiation and chemo could better control advanced nasopharyngeal cancer. It involved 60 patients in China with newly diagnosed, locally advanced disease that had not spread. The goal w…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New combo therapy tested for tough head & neck cancer
Disease control CompletedThis study tested whether adding an immunotherapy drug called nivolumab to standard chemotherapy and radiation treatment could better control nasopharyngeal cancer. It involved 40 adults with stage II-IVB cancer to see if the combined treatment was feasible and effective. The mai…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Sue Yom • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists weaponize immune cells to fight Virus-Linked cancer
Disease control CompletedThis small, early-stage trial tested a new cell therapy for people with advanced or returning nasopharyngeal cancer linked to the Epstein-Barr virus (EBV). Researchers collected and genetically engineered a patient's own immune cells (T cells) to better recognize and attack the v…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New scan combo aims to spot hidden cancer spread
Diagnosis CompletedThis study aimed to find a better way to diagnose whether small lymph nodes in the neck contain cancer that has spread from nasopharyngeal carcinoma (a type of head and neck cancer). Researchers tested a combination of MRI scans and a special contrast-enhanced ultrasound on 348 p…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC